Regulus Therapeutics Inc.

NASDAQ (USD): Regulus Therapeutics Inc. (RGLS)

Last Price

7.79

Today's Change

+4.42 (131.30%)

Day's Change

7.70 - 8.20

Trading Volume

22,009,182

Overview

Market Cap

516 Million

Shares Outstanding

66 Million

Avg Volume

1,289,788

Avg Price (50 Days)

1.68

Avg Price (200 Days)

1.56

PE Ratio

-9.51

EPS

-0.82

Earnings Announcement

07-May-2025

Previous Close

3.37

Open

7.99

Day's Range

7.7 - 8.2

Year Range

0.83 - 8.2

Trading Volume

22,017,517

Price Change Highlight

1 Day Change

131.31%

5 Day Change

176.42%

1 Month Change

350.58%

3 Month Change

679.50%

6 Month Change

399.68%

Ytd Change

399.68%

1 Year Change

238.91%

3 Year Change

310.26%

5 Year Change

52.84%

10 Year Change

-99.48%

Max Change

-98.45%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 1 of 1 comments

actvtrader

I like the 50.00 price target for yahoo!

2014-10-22 15:48

Post a Comment